All Cancer Blood test

5803912

Lung cancer, esophageal cancer, stomach cancer, colon cancer, liver cancer, gallbladder / biliary tract cancer, pancreatic cancer, renal / bladder cancer, prostate cancer

* In addition to the above items for women, breast cancer, ovarian cancer, and uterine cancer are also subject to inspection. Unlike traditional female cancer screening, there is no pain and trouble, and it is easy to conduct a wide range of medical examination without taking much time.


[Inspection item]
Male: 22 items Women: 25 items
Carcinoembryonic antigen
Beta-trace protein
Tissue plasminogen activator
Anti-p53 antibody
PIVKA-2 and alpha-fetoprotein
Carbohydrate antigen 19-9
CA19-9
SPAN-1
DUPAN-2
NCC-ST-439
SLX
STN
CA72-4
Squamous cell carcinoma antigen
CYFRA (Syrah)
Neuron Specific Enolase
Pro-gastrin-releasing peptide
CA54/61
CA125 CA602(○)
Genome amplification technologies (○)
CA15-3(○)
BCA225(○)
HER2 protein (○)
PAP(●)
High sensitivity PSA (●)
※*”●” mark is for men only.
  “○” mark is for women only.

[Flow of inspection]
1)Visit
2)Complete medical questionnaire
3)Blood Pressure Measurement
4)Measurement of body composition
5)Blood Sampling
Reservation for inspection result
※ We will accept the next reservation after the 14th day from the date of the inspection.

Aminolndex Cancer Screening

AICS (Aminolndex Cancer Screening) is a method of measuring the amino acid concentration in the blood and statistically analyzing the difference in balance between the healthy person and the amino acid concentration of a person who is cancer.This is a way to predict the risk (possibility) of cancer.

Currently, we can predict the risks for stomach cancer, lung cancer, colon cancer, prostate cancer (male only), breast cancer (female only), uterine cancer / ovarian cancer (female only).
If the AICS value is high (rank C), the risk of being cancer is also high. Therefore a precise examination of the predicted cancer is required.